Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

A picture


Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus.The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe’s most valuable company, has lost nearly $100bn (£75bn) in market value since cutting its full-year sales forecast last week, when its share price slid 30% in its worst week in more than two decades.It fell a further 3% on Wednesday.On Wednesday, Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and appetite – grew by 8% in the first half of the year, down from 21% last year.Sales of obesity drugs including Wegovy increased by 56%, taking total sales 16% higher to 155bn Danish kroner (£18bn).

Profit before tax climbed by 24% to 70,8bn kroner,The company has lost market share to its US rival Eli Lilly’s Mounjaro, which studies have shown to be more effective, as well as cheaper versions made by generic drugmakers,It has also been hit by “compounding” in the US, where pharmacies make up medications from ingredients, even though the US regulator declared an end to the practice recently,Novo Nordisk’s outgoing chief executive, Lars Fruergaard Jørgensen, said that the copycat market had “equal size to our business” and that compounded versions of Wegovy were sold at a “much lower price point”.

Its finance chief, Karsten Munk Knudsen, said the company was pursuing various strategies, including lawsuits against compounding pharmacies and expanding its US direct-to-consumer platform, NovoCare, launched in March.The company might also pursue “cash sales” directly to patients elsewhere.Jørgensen said Novo Nordisk was taking measures to “sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth”.He said it would probably not be able to avoid layoffs, but that no decision had been made.He said it would be up to Maziar Mike Doustdar, who takes over as CEO on Thursday, to make such a decision.

The company is now expecting sales growth of between 8% and 14% at constant exchange rates in 2025, down sharply from its previous estimate of 13% to 21%,Novo Nordisk also disclosed that it had ditched several weight-loss drugs in development, including one that has just completed an intermediate (phase II) clinical study, “due to portfolio considerations”,The company faces a class action lawsuit in the US from investors, who claim that it misled them with optimistic growth forecasts in the lucrative weight loss market,The UBS analyst Matthew Weston said: “We expect GLP-1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy,Sign up to Business TodayGet set for the working day – we'll point you to all the business news and analysis you need every morningafter newsletter promotion“President Trump’s proposal to reimburse GLP-1 obesity in Medicare could add significant volume uplift, but most-favoured-nation demands to offer US cash sales at European prices could significantly reduce value.

”Derren Nathan, the head of equity research at Hargreaves Lansdown, said: “Tariffs and drug pricing policy are another threat Mike Doustdar will need to tackle head-on if one of Denmark’s greatest success stories is to regain its crown as Europe’s most valuable company,“The 15% blanket rate on EU imports is not necessarily the end of the story as Donald Trump dangles the prospect of levies of up to 250% on pharmaceutical imports under a separate section 232 investigation,”
recentSee all
A picture

Bank’s base rate gift to borrowers is wrapped in an inflation warning | Phillip Inman

A reduction in interest rates by the Bank of England should rank as a joyful summer gift to borrowers weighed down by the high cost of mortgages and loans.Yet the latest quarter-point cut to the cost of borrowing, from 4.25% to 4%, is laced with so many warnings that any celebration will be muted.Most prominently, the Bank’s monetary policy committee (MPC) said in its latest assessment of the UK’s economic outlook that inflation is on course to peak at a higher rate in the second half of this year than previously forecast.Price spikes in food and energy and the higher cost of business services would push the consumer prices index to 4% in September, it said, before falling only slowly to an average of 3% in a year’s time

A picture

Another Bank of England rate cut this year less likely given inflation fears and split vote – as it happened

The chances of another cut to UK interest rates this year, to 3.75%, have fallen today, following the Bank of England’s warning that inflation will rise higher than expected this year.The closeness of this week’s vote to cut rates, with four out of nine policymakers wanting to hold rates at 4.25%, also appears to make further cuts in 2025 less likely.The money markets are now indicating that the next cut is not full priced in until February 2026

A picture

The unintended consequences of the Online Safety Act | Letters

George Billinge says that many age assurance technologies delete their personal data after age has been confirmed, while some providers of virtual private networks (VPNs) sell their data to brokers (Everything the right – and the left – are getting wrong about the Online Safety Act, 1 August). But there is a key difference: we can choose which VPN to use, but the choice of which age assurance technology to use is with the platform. When a platform I use to talk to my friends insisted I verify my age, I wasn’t given a choice about which age verification service would get my driving licence. I was expected to trust that the platform had made a good decision with my best interests at heart. That’s a pretty big ask

A picture

‘We wish it never existed’: readers tell us about their family’s use of YouTube

What role does YouTube play in the lives of Australian families with children? As the federal government plans to include YouTube in its forthcoming ban on social media accounts for children under the age of 16, Guardian readers responded to a call out about their own kids’ use of the platform and what they thought of the ban.This is what they told us.Parents frequently reported they were restricting their children’s use to shared areas by co-watching or through parental controls. But many said this was time-intensive and nearly impossible to maintain and were concerned about what content was slipping under their radar.“We use YouTube Kids and always check what they watch before we let them watch anything on there

A picture

The ultimate test: watching this glorious sporting summer has given me a headache | Emma John

There is a crick in my neck, a rick in my back, and a permanent ache behind my eyes. A friend refuses to offer sympathy. “You did this to yourself,” she says as I pop paracetamol. Thousands of hours of medical research are ploughed into elite sport, but where are the studies into the physical and mental demands of keeping up with it?While winter may be fiercely programmed, it’s the multi-disciplinary bunfight of summer that is the ultimate test of a sports fan. Right when our diaries demand we’re at our most sociable, our most available, our most outdoors, the calendar loses all sense of perspective and dumps events on us like it’s trying to save them from a burning building

A picture

Emma Raducanu: ‘I hope Francisco Roig can help me beat the top players’

Emma Raducanu believes her new coaching partnership with Francisco Roig can help to take her game to the next level as she tries to continue her recent rise up the rankings. “First impressions are it’s going really well,” Raducanu said, speaking for the first time about the move in an interview with the Guardian. “We did a few days after Wimbledon together and I was really happy with how it went. I’m just so excited to have him on board, so much experience. I’m really looking forward to continuing